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Three human brain-derived celt lines (including two of astrocytic origin) were exposed in vitro to the human 
imm~~ndeficien~y virus (HIV), the etiolo~~~ agent of imm~~deficiency in AIDS. In all three lines, HIV 
transcripts were detected by in situ hyb~dis~tion in 20-30s of cells 48 h after infection. Synthesis of virus 
gag gene products ~24 and ~5.5 was demonstrated by immunobI~tting~ No cytopathic effects typic&i of HIV- 
infected human T lymphocytes were observed, Our data indicate that HIV is ~~~ro~rop~~, and support the 
h~~othesia that this virus may infeet astrocytes in the brain. 
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One of the characteristic features of AIDS is the 
high prev~~~~e of CNS disease [l]. This ~y~~c~ly 
manifests itself as a dementia with subacute 
enceph~~~~~hy that occurs in the absence of 
recugnised ~~~~~~~~ CNS ~th~~ens [2], HIV, 
the etiofogic agent of the immune dysfuu~~~Q~ in 
AIDS (reviews [3,4]), has also been implicated in 
the AIDS-asso~ated neurolo~c~ disorders, on the 
basis of the detection of HIV genome in the brains 
of neurosymptomati~ AIDS patients [S] and isola- 
tion of the virus from the brain tissue [6]. 
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Alth~~h these data suggest that HIV could be 
neurotropic, proof that HIV can directly infect 
nervous system (NS)-derived cells, such as 
astrocytes, has been lacking. 
WC! have recently demonstrated that several cell 
lines originating from human brain tumors express 
gene transcripts encoding the helper T l~phoc~e- 
specific T4 glycopratein [7], which also serves as a 
cellular eceptor far HIV f&9]. Furthermore, two 
such cell lines exbibit~d detectab1~ levels of the 
HIV receptors an cell surfaces [7]., suggesting that 
they may be susceptible to the virus. Here we pre- 
sent data showing that T4~4~“p#sitive human 
astrocytes can be infected by HIV in vitro. These 
results provide evidence for HIV ~~~rotropism and 
suggest he ~ssibility for a direct involvement of 
HIV in AIDS-related nervous system disorders. 
2. ~ATE~~A~S AND METHYLS 
Human brain tuber-derived cell lines U-25 1 MO 
[lO,ll], tr-373MO fll] and Te671 [12] were ob- 
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tamed from D.D. Bigner (U-25 1 MG) and 
American Type Culture Collection (ATCC, 
Rockville, MD). The T4+ cell line of human T cell 
leukemia origin, CEM [13], was obtained from L. 
Montagnier .
2.2. Preparation of subgenomic HIV RNA probes 
Restriction endonuclease map of HIV molecular 
clones N 1 G-B and N 1 G-G, and the respective posi- 
tions of subcloned subgenomic fragments used for 
the generation of RNA probes are illustrated in 
fig.lF. Molecular clones NlG-B and NlG-G were 
derived from CEM cells infected with NlG isolate 
of HIV [14]. The pGAP probe was derived by 
subcloning the 2.6-kb BgflI-EcoRI fragment of 
HIV clone NlG-B in forward orientation into the 
BarnHI-EcoRI sites of pGEM3 (Promega Biotec). 
The pGgag and pGenv were made by subcloning 
the 1.4-kb SacI-BglII or the 2.1-kb KpnI-BamHI 
fragment from HIV clone NlG-G into the SacI- 
BamHI sites or the KpnI-BamHI sites of pGEM-4 
(Promega Biotec), respectively. A 32P-labelled an- 
tisense RNA probe was transcribed from pGEM-3 
and pGEM-4 vectors using the T7 promoter of the 
HindIII-linear transcription plasmid template. 
2.3. Detection of HIV expression by hybridisation 
in situ 
Cells were washed and harvested at 48 h post- 
infection. CEM/LAV-NlT [14] producer cells 
were included as positive controls. Smears of fixed 
cells were taken through a modified prehybridisa- 
tion procedure [15] prior to overnight incubation 
with a PhotobiotinTM [16]-labelled antisense 
single-stranded RNA probe. The probe consisted 
of pGAP, pGgag and pGenv combined in equal 
amounts in hybridisation cocktail as described 
[ 161. Following hybridisation, slides were treated 
with RNase and washed. Hybrids were detected by 
incubation of the slides with streptavidin- 
conjugated Texas red according to the manufac- 
turer’s instructions (BRL). Photographs were 
taken on a Nikon microscope using Kodak 
Ektachrome PS 800/1600 film push processed at 
1600 ASA. All slides were photographed with the 
same exposure time so as to allow direct com- 
parison of the relative levels of fluorescence. 
2.4. Immunocytochemical staining of ceils for 
GFAP 
Acetone fixed cell smears were reacted with 
GFAP-specific monoclonal antibodies (G-A-5, ob- 
tained from Boehringer-Mannheim and used at a 
concentration of 5-10 fig/ml). Detection of bound 
antibody was achieved by the avidin-biotin- 
peroxidase method (Vector Laboratories). 
2.5. Immunoprecipitation-enriched immunoblot 
analysis 
Cell extracts were immunoprecipitated using 
monoclonal antibodies to virus gag gene products 
~55 and p24 (Chemicon International), prior to 
electrophoresis and transfer to nitrocellulose [ 171. 
Filters were incubated with antibody at 1: 1000 
dilution at 37°C overnight prior to detection using 
gold-conjugated anti-mouse immunoglobulin 
(Boehringer Mannheim) and silver enhancement 
(IntenSE, Boehringer Mannheim). 
3. RESULTS 
The principal characteristics of the three NS- 
derived cell lines used in the present study are sum- 
marized in table 1. None of the cell lines expressed 
epithelial cell markers (EMA, V-72-3, keratin), nor 
did they bind the monoclonal antibodies OKM-1 
and OKM-3, indicating that they were not of the 
monocyte/macrophage series. All the cell lines 
were also free of T-lymphocytic characteristics, as 
assessed by Northern blot analysis with probes 
recognizing the constant region of the T-cell recep- 
tor. We may thus conclude that the cell lines tested 
were free of contamination by known HIV-host 
cells, i.e., monocyte/macrophages and T lym- 
phocytes. Two of the cell lines expressed the 
astrocyte-specific marker, GFAP, as detected by 
immunocytochemistry and molecular hybridisa- 
tion with a GFAP cDNA probe (fig.2E). As 
reported previously, all three cell lines expressed 
elevated levels of mRNA encoding the T4 receptor 
for HIV (table 1 and [7]). 
For infection studies, glial cell cultures were ex- 
posed overnight to HIV-containing culture super- 
natants from HIV-producer cells GEM/HIV [13], 
followed by washing and analysis for the expres- 
sion of viral products at various time points. Virus 
genome transcription was demonstrated by 
hybridisation in situ 48 h after infection (fig.1). 
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Table 1 
Characterisation of human NS-derived cell lines and their response to HIV infection 
Cell line Origin Characteristics of uninfected cells Parameters of HIV infection 
7 days after exposure to the virus 
Monocyte/ T-lympho- T4 GFAPC l 
macrophage cytic mRNA HIV HIV antigens Cytopathic 
markersa character- transcriptsd effects’ 
isticsb IF IPfWB 
U-25lMG glioma - + + + _ + - 
U-373MG glioblastoma - + + f - + - 
Te67 1 medullo- 
blastoma - + + - i” _ 
CEM T ceii 
leukemia - + + + + + + 
a OKMl, 0KM3 
b T cell receptor gene rearrangement, CT gene expression 
’ By molecular hybridisation, immunocytochemistry 
d By in situ hybridisation (fig.1) and Northern blotting (not shown) 
e Cell lysis, formation of syncytia 
IF, indirect immunofluorescence on smears of acetone-fixed cells; IPIWB, immunoprecipitation-enriched Western 
blotting (see also fig.2) 
Virally encoded messsages were detected using 
subgenomic antisense HIV RNA probes (fig. 1F) in 
approx. 30% of virus producing GEM/HIV cells 
(fig.lA) and 20% of infected brain-derived cells 
(fig.lB,D). In contrast, uninfected cells did not 
hybridise with these probes (fig.IC), and control 
hybridisations using RNA probes of opposite 
orientation (i.e., sense) also showed no reaction. A 
comparison of fig. 1 D and E clearly reveals that the 
GFAP-positive and virus infectable U-373MG cell 
populations (90 and 20%, respectively) must 
overlap, thereby demonstrating that cells of 
astrocytic origin are, indeed, infectable by HIV. 
The detection of viral RNA transcripts by in situ 
hybridisation was confirmed by RNA blot analysis 
2 and 7 days after infection (not shown). 
The translation of viral gene transcripts was 
demonstrated by immunoprecipitation-enriched 
immunoblot analysis using monoclonal antibodies 
to HIV gag gene products (fig.2). Viral polypep- 
tides ~55 and p24 were identified in glial cell ex- 
tracts 48 h after infection, albeit at reduced levels 
in comparison to HIV-infected T4+ lymphocytic 
cells CR-lo/HIV [ 18) (fig.2). No virus-specific an- 
tigens could be detected by indirect im- 
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munofluorescence staining (table I), confirming 
the low-level production of viral structure pro- 
teins in these cells. The production of mature 
progeny virus by HIV-infected NS-derived cells 
was demonstrated by cocultivation assays using 
PHA/IL-2 stimulated peripheral blood lym- 
phocytes. Reverse transcriptase assays performed 
on supernatants from such cultures indicated that 
low levels of virus replication occurred in brain cell 
lines up to 7 days after infection with HIV. Infec- 
tious progeny virus was also obtained after 
transfection of glial cells with biologically active 
recombinant clones of HIV (not shown), confirm- 
ing that these cells are permissive to HIV infection 
and replication. 
In contrast to HIV-infected T lymphocytes, no 
cytopathic effects (cell lysis, formation of syncytia, 
growth retardation) were observed during short- or 
long-term culture of HIV-infected glial cells (table 
1). However, the long-term infected cultures were 
found to contain viral gene transcripts and express 
the tatHIV gene-encoded transactivation function 
[ 191 as detected by the chloramphenicol acetyl 
transferase (CAT) assay, but did not release infec- 
tious virus particles (not shown). 
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Fig.1. A-D: In situ hybridisation of fixed cell smears from HIV-infected cell cultures (A, GEM/HIV producer cells; 
B, Te671 cells; D, U-373MG cells) or control uninfected cells (C, U-373MG) with HIV-specific RNA probes. 
Magnification x 455. E: Immunocytochemical staining of U-373MG cells for GFAP. Magnification x 525. F: 
Restriction endonuclease map of HIV clones with areas covered by RNA probes indicated. Enzyme cleavage sites: Ba, 
BarnHI; B, BgAI; E, EcoRI; H, HindIII; K, KpnI; Ps, PstI; P, PvuII; S, SacI; Sa, WI; X, XhoI. 
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Fig.2. Immunoblot analysis of HIV-specific protein 
synthesis in infected cell lines using monoclonal 
antibodies to gag gene products p55 and ~24. 
CR-IO/HIV [ 181 lane represents an extract of less than 
2 x lo6 cells, whereas all other lanes represent over 20 x 
lo6 cells. Numbers on the left refer to molecular mass 
markers. 
4. CONCLUSIONS ACKNOWLEDGEMENTS 
The results presented here demonstrate that 
human astrocytes can be directly infected by the 
AIDS virus in vitro. This finding is consistent with 
our recent report showing the expression of the 
HIV receptor (T4 molecule) by these cells [7]. 
Taken together with previous reports on the pro- 
bable localisation of HIV genome in astrocytes in 
brain autopsy materials from AIDS patients 
[20,21], our data strongly suggest that strocytes, 
and possibly other NS-derived cells, may serve as 
the cellular targets for HIV neurotropism within 
the CNS. 
It is of interest that virus activity in HIV- 
infected NS-derived cells was reduced in com- 
parison to T-lymphocytic cells at both transcrip- 
tional and translational levels (figs 1 and 2). 
Furthermore, viral replication in these cells ap- 
peared to decline rapidly during culture (being 
undetectable 14 days after infection). Although the 
observed decline could be the result of a transient 
infection, it may also be due to the establishment 
of a state of viral latency. The latter hypothesis is 
supported by our preliminary experiments howing 
the persistence of certain viral transcripts and 
regulatory functions, such as the transcriptional 
transactivation, in long-term cultures of HIV- 
infected glial cells. The observation that HIV did 
not induce cytopathic effects in glial cells at any 
time after virus exposure (table 1) can be inter- 
preted as another indication that the pathway of 
HIV infection in NS-derived cells differs markedly 
from the highly replicative and cytopathic interac- 
tion of the virus with human T lymphocytes. 
While HIV can frequently be detected in 
macrophages in the brains of AIDS patients af- 
flicted with neurological disorders [22,23], the 
localisation of the virus to astrocytes and other 
NS-derived cells in vivo has been achieved only 
rarely, and then, usually in patients at a severe 
stage of the disease [20,21]. Since our data indicate 
that in vitro infected NS cells express only low 
levels of HIV gene products, it is conceivable that 
the convincing proof for HIV neurotropism in vivo 
has to await more sensitive techniques for the 
detection of latent HIV infections in clinical 
materials. 
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